Publisher： Bentham Science Publishers
E-ISSN： 1873-4294|17|1|59-70
ISSN： 1568-0266
Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.1, 2017-01, pp. : 59-70
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The need for novel approaches for targeting well-known protein families in drug discovery has been discussed for several years. There is a huge amount of literature on the inhibition of kinases with small molecules targeting the ATP site, and as a result of this extensive research, there are a large number of kinase inhibitors in the clinic. However, even though the idea of targeting other sites on kinases is not new, relatively little has been reported. In this review we give an overview of structurally characterized allosteric kinase inhibitors, outline the benefits of these with the use of case studies and then discuss the challenges that need to be overcome and the opportunities for doing this.
Related content
Allosteric p38 kinase inhibitors
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. :
Access to resources
Recommend
Kinase targets in inflammation
Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. :
Virtual Screening for Kinase Targets
Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. :
Molecular Targets for Modulating Lung Inflammation and Injury
Current Drug Targets, Vol. 5, Iss. 6, 2004-08 ,pp. :